KDM1A and neoplasm: These studies show that the anti-tumor effect of CAR T cells can be improved by inhibiting LSD1 activity, which providing a new auxiliary strategy for improving the efficacy of CAR T cell therapy, and giving a new idea for CAR T cell design.